Skip to content
PubMed This is a summary of 81 peer-reviewed journal articles Updated
Cardiology · Heart Failure with Reduced Ejection Fraction

Systolic Heart Failure (HFrEF): A Patient Guide

At a Glance

Systolic heart failure (HFrEF) weakens the heart’s pumping ability, but treatment can improve symptoms and heart function. Four medication pillars, regular follow-up, and daily weight and symptom tracking help manage the condition, and medicines usually continue even after improvement.

Systolic Heart Failure, often called Heart Failure with reduced Ejection Fraction (HFrEF), is a clinical condition where the heart muscle has become too weak to pump blood throughout the body as effectively as it should. This often happens because the heart’s main pumping chamber has stretched or weakened, leaving it unable to squeeze with enough force to meet the body’s needs [1]. While the name can sound final, heart failure does not mean the heart has stopped; rather, it describes a heart that is working under significant stress. Understanding this distinction is the first step toward a proactive and empowered approach to managing your health [2].

The modern approach to treating HFrEF has shifted to actively protecting the heart muscle and managing symptoms. This is achieved through Guideline-Directed Medical Therapy (GDMT), a combination of four distinct classes of medication often referred to as the four pillars. These therapies work in harmony to block the hormonal signals that cause the heart to weaken further, helping shield the heart from the body’s own stress responses [3]. By starting these treatments early and staying consistent, many patients find that their symptoms decrease and their risk of hospitalization is reduced. GDMT is highly individualized, and it does not replace treating the underlying cause, such as blocked arteries or valve disease.

One of the encouraging possibilities in heart failure care is a state known as HFimpEF, where the heart’s pumping ability improves significantly after several months of proper therapy. It is important to view this improvement as a form of remission rather than a guaranteed permanent cure. Because the medications are the very tools allowing the heart to function better, they usually remain a lifelong requirement to prevent the heart from falling back into a weakened state [4]. Maintaining this stability requires a partnership between you and your care team.

Beyond medication, living well with HFrEF involves a daily commitment to self-monitoring and awareness. By tracking simple metrics like your morning weight and paying attention to how your body handles salt and fluid, you can catch small changes before they become serious issues. This daily vigilance, combined with modern medical therapies, helps manage HFrEF as a chronic condition. While the journey requires adjustments, a strong, well-managed treatment plan can help you maximize your quality of life [5].

Common questions in this guide

What is systolic heart failure (HFrEF)?
Systolic heart failure, also called heart failure with reduced ejection fraction, occurs when the heart muscle is too weak to squeeze and pump blood effectively. The name describes reduced pumping strength; it does not mean the heart has stopped.
What are the four pillars of HFrEF treatment?
The four pillars are four types of guideline-directed medicines used together to protect the heart and counter body signals that can make it weaker. Your healthcare team chooses and adjusts these medicines based on your health, symptoms, and other treatments.
Can my heart function improve after an HFrEF diagnosis?
Yes. Some people develop heart failure with improved ejection fraction, or HFimpEF, after months of effective treatment. Improvement is generally considered remission rather than a guaranteed permanent cure, so follow-up remains important.
Will I need HFrEF medicines if my heart function improves?
Usually, medicines are continued even when pumping ability improves because they helped the heart recover and can reduce the chance of becoming weak again. Do not stop or change them without speaking with your healthcare team.
How can I monitor systolic heart failure at home?
Weigh yourself in the morning as directed and pay attention to changes in symptoms, energy, and how your body responds to salt and fluids. Share concerning changes with your care team and follow the personal instructions they give you.
How will my doctor know whether HFrEF treatment is working?
Your care team can review your symptoms, daily measurements, and heart function over time to judge how well treatment is working. The timing of heart-function checks depends on your health and treatment plan, so ask when your next assessment is due.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current health, what is the primary goal of my treatment plan right now?
  2. 2.How often will we check my heart function to see if my medications are working?
  3. 3.What lifestyle adjustments are most critical for me to focus on this month?
  4. 4.Are there specific support groups or resources you recommend for people living with HFrEF?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (5)
  1. 1

    Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

    Bozkurt B, Coats AJS, Tsutsui H, et al.

    European journal of heart failure 2021; (23(3)):352-380 doi:10.1002/ejhf.2115.

    PMID: 33605000
  2. 2

    Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment.

    Shang Z, Wang X, Gao W

    Reviews in cardiovascular medicine 2022; (23(1)):30 doi:10.31083/j.rcm2301030.

    PMID: 35092222
  3. 3

    Guidelines for treating heart failure.

    Kittleson MM

    Trends in cardiovascular medicine 2025; (35(3)):141-150 doi:10.1016/j.tcm.2024.10.002.

    PMID: 39442740
  4. 4

    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

    Heidenreich PA, Bozkurt B, Aguilar D, et al.

    Journal of the American College of Cardiology 2022; (79(17)):1757-1780 doi:10.1016/j.jacc.2021.12.011.

    PMID: 35379504
  5. 5

    Tailoring guideline-directed medical therapy in heart failure with reduced ejection fraction: A practical guide.

    Kapłon-Cieślicka A, Vardas P, Grabowski M, Lelonek M

    Kardiologia polska 2023; (81(9)):850-858 doi:10.33963/v.kp.97062.

    PMID: 37794739

This page explains HFrEF treatment and daily self-monitoring for educational purposes only; it does not replace personalized medical advice from your healthcare team.

Get notified when new evidence is published on systolic heart failure.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.